[CLDX] YoY Quarter Result on 30-Jun-2013 [#Q2]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
06-Aug-2013
Financial Year
2013
Quarter
30-Jun-2013 [#Q2]
Profit Trend
QoQ- -9.72%
YoY- -38.07%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Revenue 1,389 2,178 592 97 2,009 1,952 2,951 -11.79%
PBT -31,952 -32,359 -28,274 -19,016 -13,362 -9,802 -9,191 23.05%
Tax -828 -782 -275 -161 -252 -158 -190 27.77%
NP -31,952 -32,359 -28,274 -19,016 -13,773 -10,236 -9,525 22.32%
Tax Rate - - - - - - - -
Total Cost 33,341 34,537 28,866 19,113 15,782 12,188 12,476 17.78%
Ratio Analysis
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
NP Margin -2,300.36 -1,485.72 -4,776.01 -19,604.12 -685.56 -524.39 -322.77 38.68%
Per Share
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
EPS -4.85 -4.93 -4.75 -3.53 -3.52 -4.10 -4.49 1.29%
EPS Diluted -4.85 -4.93 -4.75 -3.53 -3.52 -4.10 -4.49 1.29%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.